SR One Capital Management is a prominent trans-Atlantic biotech venture capital firm that collaborates with visionary entrepreneurs, esteemed scientists, and investment partners to establish exceptional biotechnology companies. With a steadfast commitment to translating groundbreaking technologies into next-generation medicines, our mission is to address significant unmet medical needs and enhance patient outcomes. At SR One, we focus on building elite life sciences companies, and our portfolio consists of noteworthy companies that are revolutionizing medical advancements.

These companies are rewriting medical textbooks by transforming ingenious discoveries into transformative therapies. Our dedication to key disease areas and various modalities ensures that innovation is embedded in our DNA. We are driven by a patient-centric approach, striving to bridge therapeutic gaps in areas such as oncology, immunology, rare diseases, and more.

By closing these gaps, our portfolio companies have the ability to spearhead new paradigms in medicine. With a trans-Atlantic presence, we have access to top scientific expertise across different geographies. Our integrated team is situated in key biotech hubs on the West and East Coast of the USA, as well as in London, UK.

Our rich venture creation history dates back to 1985, fueling our commitment to fostering innovation. Join us on our journey to revolutionize biotech and make a positive impact in the lives of patients worldwide